Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 191, pseudogene (RN7SL191P) is a human pseudogene classified as a non-coding RNA and part of the large family of 7SL RNA-derived pseudogenes[1][6]. It is located on chromosome X[6]. The canonical 7SL RNA is a structural and enzymatic RNA central to the signal recognition particle (SRP), a ribonucleoprotein complex that mediates targeting of secretory and membrane proteins during translation[3][5][7]. However, as a pseudogene, RN7SL191P is not believed to have a protein-coding, structural, or canonical biological function, nor is it known to be a direct therapeutic target or disease biomarker. No interacting drugs or specific disease associations are currently attributed to this pseudogene. While there is emerging evidence that some pseudogenes may play regulatory roles or participate as non-coding RNA regulators in select contexts[4], there are no published data supporting such a role for RN7SL191P specifically. Notes and rationale: - This entry is a pseudogene, not a receptor or therapeutic target, so is_target is false[1][6]. - It is not known to be functionally active, and there is no evidence for direct involvement in disease, drug interaction, or biomarker status. - The entry is likely only relevant for genomic annotation and evolutionary study. - is_incorrect is marked true because this molecule does not meet criteria of a therapeutically relevant target (e.g., receptor, enzyme, transporter, etc.), and could be misleading in a therapeutic context[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 191, pseudogene (RN7SL191P).